Proteostasis (in)action: the role of co-pathologies in neurodegenerative disease
Philosophical Transactions of the Royal Society B: Biological Sciences · 2026
DOI: 10.1098/rstb.2025.0273 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Philosophical Transactions of the Royal Society B: Biological Sciences, 2026. Verfasst von James F Morley. Beteiligte Einrichtung: Parkinson's Disease Research, Education and Clinical Center, US Department of Veterans Affairs , Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Proteostasis, Neurodegenerative Diseases. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Clinically distinct neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), share in common progressive neuronal dysfunction and cell death associated with the accumulation of misfolded proteins. Central to these processes are the cellular and organismal proteostasis networks responsible for maintaining protein homeostasis through coordinated actions of molecular chaperones, the ubiquitin–proteasome system and autophagy–lysosomal pathways. As a consequence of ageing, genetic modifications and other disease-specific conditions, the proteostatic network becomes compromised, leading to the accumulation of toxic protein aggregates that disrupt neuronal function and lead to neurodegeneration. Specific misfolded proteins are associated with each neurodegenerative disease (i.e. α-synuclein in PD, amyloid-β/tau in AD and TAR DNA-binding protein 43/SOD in ALS). However, increasing evidence implicates more complex interactions of co-pathologies across these disorders, as Lewy bodies are common in AD brains and Alzheimer pathology is present in the majority of PD autopsy cases. These observations are consistent with the idea that disruption of proteostasis networks by one aggregation-prone protein could result in misfolding and aggregation of other neurodegeneration-related species. This review will examine the characteristics and consequences of co-pathologies in neurodegenerative disorders. Additionally, the review will outline emerging therapeutic strategies targeted at restoring proteostasis and mitigating the effects of co-pathological processes associated with neurodegenerative diseases. This article is part of the Theo Murphy meeting issue ‘ProteostaSys: a systems view of proteostasis’.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Parkinson's Disease Research, Education and Clinical Center, US Department of Veterans Affairs , Philadelphia, PA, USA.
- Neurology, University of Pennsylvania, Perelman School of Medicine , Philadelphia, PA, USA.
ORCID-Profile: James F Morley
Zitieren
APA
Morley, J. F. (2026). Proteostasis (in)action: the role of co-pathologies in neurodegenerative disease. Philosophical Transactions of the Royal Society B: Biological Sciences. https://doi.org/10.1098/rstb.2025.0273
Vancouver
Morley JF. Proteostasis (in)action: the role of co-pathologies in neurodegenerative disease. Philosophical Transactions of the Royal Society B: Biological Sciences. 2026. doi:10.1098/rstb.2025.0273
BibTeX
@article{Morley2026,
author = {Morley, James F},
title = {Proteostasis (in)action: the role of co-pathologies in neurodegenerative disease},
journal = {Philosophical Transactions of the Royal Society B: Biological Sciences},
year = {2026},
doi = {10.1098/rstb.2025.0273}
}
EUVIMED